{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:49:43Z","timestamp":1760608183257,"version":"3.40.4"},"reference-count":10,"publisher":"S. Karger AG","issue":"6","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"},{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Nephrol"],"published-print":{"date-parts":[[2004]]},"abstract":"<jats:p>&lt;i&gt;Background:&lt;\/i&gt; Neuromyopathy was reported to be a problem among live donor familial Mediterranean fever (FMF) amyloid kidney transplant recipients. We aimed to address this issue on a long-term basis. &lt;i&gt;Methods:&lt;\/i&gt; 14 FMF amyloid live donor kidney transplant recipients with a mean post-transplant follow-up period of 82.43 \u00b1 50.1 months in comparison to a control group of 19 non-amyloid renal transplant patients were subjected to thorough neurological examination, laboratory and electrophysiologic studies. &lt;i&gt;Results:&lt;\/i&gt; Both groups were comparable with regard to mean serum creatinine levels cyclosporine doses (p &gt; 0.05), however trough cyclosporine levels were significantly lower in the amyloidotics than the controls (p = 0.04). Serum creatine phosphokinase was comparable in both groups (p = 0.59). The amyloid patients showed significantly increased polyphasic motor unit potentials and abnormal interference patterns in the biceps brachii muscle (p = 0.03) and the abductor polices brevis muscle (p = 0.05). Multivariate analysis showed a significant level for biceps myopathy in amyloidotics (p = 0.001). Both groups attained no difference with regard to median nerve conduction velocity. &lt;i&gt;Conclusion:&lt;\/i&gt; Electrophysiologically evidenced neuromyopathy is more liable to occur in long-term live donor FMF amyloidotic kidney transplant recipients than in the other non-amyloidotic kidney transplant recipients even with no clinical manifestations or high creatine phosphokinase levels.<\/jats:p>","DOI":"10.1159\/000082251","type":"journal-article","created":{"date-parts":[[2004,12,3]],"date-time":"2004-12-03T12:13:58Z","timestamp":1102076038000},"page":"582-586","source":"Crossref","is-referenced-by-count":4,"title":["Long-Term Evaluation of Neuromyopathy in Live Donor FMF Amyloidotic Kidney Transplant Recipients"],"prefix":"10.1159","volume":"24","author":[{"given":"Ali M.","family":"Sherif","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman F.","family":"Refaie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussein A.","family":"Sheashaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abd-Elhalim","family":"El-Tantawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A.","family":"Sobh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"127","published-online":{"date-parts":[[2005,2,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016%2FS0272-6386%2803%2900676-0"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016%2FS0303-8467%2897%2900092-9"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1159%2F000168981"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111%2Fj.1432-2277.2002.tb00181.x"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093%2Fndt%2F12.11.2389"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093%2Fndt%2F12.10.2204a"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097%2F00007890-199206000-00039"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097%2F00007890-199006000-00041"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056%2FNEJM198706183162502"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016%2F0140-6736%2890%2990924-T"}],"container-title":["American Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/82251","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/82251","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T03:21:26Z","timestamp":1745464886000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000082251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004]]},"references-count":10,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2004,12,1]]}},"URL":"https:\/\/doi.org\/10.1159\/000082251","archive":["Portico"],"relation":{},"ISSN":["0250-8095","1421-9670"],"issn-type":[{"type":"print","value":"0250-8095"},{"type":"electronic","value":"1421-9670"}],"subject":[],"published":{"date-parts":[[2004]]}}}